Population: Japanese; Derived from sampling site: Peripheral blood.
Omics: Deep antibody staining analysis; Omics: Deep exome analysis; Omics: Deep promoter analysis; Omics: Deep quantitative proteome analysis; Omics: Deep RNAseq analysis; Omics: DNA methylation analysis; Omics: Glycoproteome analysis by proteomics; Omics: Protein expression by reverse-phase protein arrays; Omics: shRNA library screening; Omics: SNP array analysis; Omics: Transcriptome analysis
Characteristics: Can differentiate from monocytes into macrophage-like cells upon stimulation with PMA
Caution: NRAS mutation indicated incorrectly as being p.Gly12Ser in PubMed=9379676
Group: Space-flown cell line (cellonaut); Part of: Cancer Cell Line Encyclopedia (CCLE) project; Part of: COSMIC cell lines project; Part of: LL-100 blood cancer cell line panel; Part of: MD Anderson Cell Lines Project; Part of: RAS genetic alteration cell panel (ATCC TCP-1031); Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981)
HLA typing: A*02; B*15:11; C*03; DQB1*05,06; DRB1*01,15; DRB5*01/02 (PubMed=22674354); Genome ancestry: African=0%; Native American=0.3%; East Asian, North=77.63%; East Asian, South=20.4%; South Asian=1.67%; European, North=0%; European, South=0% (PubMed=30894373)
Anecdotal: Have been flown in space on Cosmos-2044 to study the inhibition of phorbol ester-induced cell activation in microgravity (PubMed=352912)